Literature DB >> 10705704

The cost of health conditions in a health maintenance organization.

G T Ray1, F Collin, T Lieu, B Fireman, C J Colby, C P Quesenberry, S K Van den Eeden, J V Selby.   

Abstract

In this retrospective cohort analysis of all adults who were members of Kaiser Permanente, Northern California, between July 1995 and June 1996 (N = 2,076,303), the authors estimated the prevalence, average annual costs per person, and percentage of total direct medical expenditures attributable to each of 25 chronic and acute conditions. Ordinary least squares regression was used to adjust for age, gender, and comorbidities. The costs attributable to the 25 conditions accounted for 78 percent of the health maintenance organization's total direct medical expense for this age-group. Injury accounted for a higher proportion (11.5 percent) of expenditures than any other single condition. Three cardiovascular conditions--ischemic heart disease, hypertension, and congestive heart failure--together accounted for 17 percent of direct medical expense and separately accounted for 6.8 percent, 5.7 percent, and 4.0 percent, respectively. Renal failure ($22,636), colorectal cancer ($10,506), pneumonia ($9,499), and lung cancer ($8,612) were the most expensive conditions per person per year.

Entities:  

Mesh:

Year:  2000        PMID: 10705704     DOI: 10.1177/107755870005700106

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  24 in total

1.  The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients.

Authors:  Jennifer R Mertens; Alan J Flisher; Derek D Satre; Constance M Weisner
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

2.  Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.

Authors:  Cynthia I Campbell; Sujaya Parthasarathy; Kelly C Young-Wolff; Derek D Satre
Journal:  J Psychoactive Drugs       Date:  2017-04-20

3.  Chronic Condition Combinations and Productivity Loss Among Employed Nonelderly Adults (18 to 64 Years).

Authors:  Abdulkarim M Meraya; Usha Sambamoorthi
Journal:  J Occup Environ Med       Date:  2016-10       Impact factor: 2.162

4.  Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma.

Authors:  G Thomas Ray; Jennifer R Mertens; Constance Weisner
Journal:  Addiction       Date:  2009-02       Impact factor: 6.526

5.  Impact of chronic conditions on the cost of cancer care for Medicaid beneficiaries.

Authors:  Sujha Subramanian; Florence K L Tangka; Susan A Sabatino; David Howard; Lisa C Richardson; Susan Haber; Michael T Halpern; Sonja Hoover
Journal:  Medicare Medicaid Res Rev       Date:  2013-01-17

6.  Using GIS to profile health-care costs of VA Quality-Enhancement Research Initiative diseases.

Authors:  Wei Yu; Diane Cowper; Magdalena Berger; Mark Kuebeler; Joe Kubal; Larry Manheim
Journal:  J Med Syst       Date:  2004-06       Impact factor: 4.460

7.  Using GIS in government: an overview of the VHA's Healthcare Atlas, FY-2000.

Authors:  Diane Cowper; W Yu; Mark Kuebeler; Joseph D Kubal; Larry M Manheim; Bruce A Ripley
Journal:  J Med Syst       Date:  2004-06       Impact factor: 4.460

8.  Can managed health care help manage health care-associated infections?

Authors:  R Platt; B Caldwell
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

9.  Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?

Authors:  Theodore A Omachi; Steven E Gregorich; Mark D Eisner; Renee A Penaloza; Irina V Tolstykh; Edward H Yelin; Carlos Iribarren; R Adams Dudley; Paul D Blanc
Journal:  Med Care       Date:  2013-08       Impact factor: 2.983

Review 10.  Assigning resources to health care use for health services research: options and consequences.

Authors:  Paul A Fishman; Mark C Hornbrook
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.